Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Ductal and Invasive Lobular Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01208974
What this trial is testing

Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction

Who this might be right for
Breast CancerDuctal Carcinoma
University of Miami 21
Not applicableLooking for participantsNCT06903468
What this trial is testing

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

Who this might be right for
Ductal Carcinoma in SituBreast Cancer
University of Florida 50
Not applicableWithdrawnNCT04349111
What this trial is testing

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma In Situ
Xoft, Inc.
Testing effectiveness (Phase 2)Study completedNCT01417286
What this trial is testing

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

Who this might be right for
Inflammatory Breast CancerInvasive Ductal Breast CarcinomaInvasive Lobular Breast Carcinoma+7 more
Rutgers, The State University of New Jersey 69
Testing effectiveness (Phase 2)Looking for participantsNCT05919108
What this trial is testing

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Who this might be right for
Anatomic Stage I Breast CancerAnatomic Stage II Breast CancerAnatomic Stage III Breast Cancer+1 more
Vanderbilt-Ingram Cancer Center 30
Not applicableStudy completedNCT01060085
What this trial is testing

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

Who this might be right for
Ductal Carcinoma In SituInvasive Breast Cancer
Dartmouth-Hitchcock Medical Center 51
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT01023477
What this trial is testing

Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)

Who this might be right for
Carcinoma, Intraductal, NoninfiltratingDCISDuctal Carcinoma In Situ
Inova Health Care Services 12
Not applicableStudy completedNCT05012176
What this trial is testing

An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+21 more
Ohio State University Comprehensive Cancer Center 50
Very early researchWithdrawnNCT01055678
What this trial is testing

To Evaluate the Characteristics of a Breast Cancer

Who this might be right for
Breast Cancer
Mark Dewhirst
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Early research (Phase 1)Study completedNCT01791478
What this trial is testing

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerInvasive Ductal Breast Carcinoma+3 more
Vanderbilt-Ingram Cancer Center 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023967
What this trial is testing

Metformin and Nightly Fasting in Women With Early Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Breast Ductal Carcinoma In Situ+1 more
M.D. Anderson Cancer Center 120
Early research (Phase 1)Ended earlyNCT02876640
What this trial is testing

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+6 more
National Cancer Institute (NCI) 27
Not applicableStudy completedNCT00058058
What this trial is testing

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Who this might be right for
Breast CancerContralateral Breast Cancer
American College of Radiology Imaging Network 1,007
Not applicableActive Not RecruitingNCT05318274
What this trial is testing

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Who this might be right for
Ductal Breast Carcinoma in SituInvasive Breast CancerEarly-stage Breast Cancer+4 more
Coordinación de Investigación en Salud, Mexico 72
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableWithdrawnNCT03437915
What this trial is testing

BrUOG 351: PRE-OPERATIVE APBI USING NIBB

Who this might be right for
Breast CancerInvasive Breast CancerDuctal Carcinoma in Situ
Jaroslaw Hepel
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009044
What this trial is testing

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Who this might be right for
Cancer SurvivorDuctal Breast Carcinoma In SituInvasive Breast Carcinoma
Northwestern University 156
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Next Page